Liver Transplantation for Hepatocellular Carcinoma: Five Steps to Prevent Recurrence
Authors:
Open Access
- 10 August 2011
- journal article
- research article
- Published by Elsevier in American Journal of Transplantation
- Vol. 11 (10) , 2031-2035
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- MicroRNA-Based Classification of Hepatocellular Carcinoma and Oncogenic Role of miR-517aGastroenterology, 2011
- Sirolimus‐based immunosuppression is associated with increased survival after liver transplantation for hepatocellular carcinoma†Hepatology, 2010
- Molecular targeted therapies in hepatocellular carcinoma†Hepatology, 2008
- Sorafenib in Advanced Hepatocellular CarcinomaNew England Journal of Medicine, 2008
- Hepatocellular Carcinoma Recurrence and Death Following Living and Deceased Donor Liver TransplantationAmerican Journal of Transplantation, 2007
- De Novo Sirolimus-Based Immunosuppression After Liver Transplantation for Hepatocellular Carcinoma: Long-Term Outcomes and Side EffectsTransplantation, 2007
- A randomized controlled trial of licartin for preventing hepatoma recurrence after liver transplantationHepatology, 2007
- Response to Preoperative Chemoembolization Correlates with Outcome After Liver Transplantation in Patients with Hepatocellular CarcinomaLiver Transplantation, 2007
- Anterior Approach Versus Conventional Approach Right Hepatic Resection for Large Hepatocellular CarcinomaAnnals of Surgery, 2006
- α-Fetoprotein mRNA in the circulation as a predictor of postsurgical recurrence of hepatocellular carcinoma: A prospective studyHepatology, 2002